Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thoracic Diseases 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Prolactinoma 1Pituitary ACTH Hypersecretion 1Paraproteinemias 1Pancreatic Ductal Adenocarcinoma 1Nervous System Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Mesothelioma, Malignant 1Lung Neoplasms 1Leiomyosarcoma 1Immunoglobulin Light-chain Amyloidosis 1Head and Neck Neoplasms 1Gigantism 1Esophageal Neoplasms 1Endometrial Neoplasms 1Congenital Abnormalities 1Combined Pituitary Hormone Deficiency 1Colorectal Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Central Nervous System Neoplasms 1Central Nervous System Diseases 1Carcinosarcoma 1

Interventions

Dexamethasone 3Bortezomib 3Cyclophosphamide 2Clinical Protocols 2isatuximab 1daratumumab 1Tissue Banks 1Rifaximin 1Lenalidomide 1Clonal Hematopoiesis 1Chromatin Immunoprecipitation Sequencing 1CLR1404 1Blood Cell Count 1ARQ531 14-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paraproteinemias × Tissue Banks × 1 year × Clear all
NCT01408225 2026-03-23

B-SCR-MM

Ohio State University Comprehensive Cancer Center

Recruiting
5,000 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡